‹ All Posts
Prachi Mehta

17th Dec · SEBI-Registered Analyst

Stocks in news today

GLENMARK
’ wholly owned subsidiary -- Glenmark Specialty S.A. (GSSA) has entered into an exclusive license, collaboration and distribution agreement with Jiangsu Hansoh Pharmaceutical Group Co., (Hansoh Pharma) for Aumolertinib, a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) for the treatment of non-small cell lung cancer (NSCLC). Under the terms of the agreement, Glenmark receives exclusive rights to develop and commercialize Aumolertinib across its licensed territories: Middle East and Africa, Southeast & South Asia, Australia, New Zealand, Russia/CIS and a few selected Caribbean countries covered by the agreement. !J K Phillips LLP, a 50:50 Joint Venture between Jaykay Enterprises and Phillips Machine Tools India (a subsidiary of Phillips Corporation, USA), has received an Order/Letter of Acceptance (LOA) from Ircon International Limited (a Navratna Company and a Govt. of India Undertaking) for a contract value of Rs 162.25 crore (including GST).
SAREGAMA
and Sanjay Leela Bhansali promoted Bhansali Productions, one of India’s most respected and financially robust film production houses, have entered into a strategic partnership anchored by a significant equity investment by Saregama in Bhansali Productions. This partnership brings together Bhansali Productions’ globally recognised, distinctive and unmatched cinematic storytelling with Saregama’s leadership position in Music and Live Events, thus building a next-generation media and entertainment house.

#WatchOutFor#StockInNews#FundamentalViews#TechnicalViews#EquityResearch
578 likes·27 comments